Los Angeles Capital Management
GBIO

Los Angeles Capital Management’s Generation Bio GBIO Stock Holding History

Los Angeles Capital Management’s Portfolio GBIO Stock Details GBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-37,891
Closed -$153K – 1385
2025
Q1 		$153K Buy
37,891
+13,298
+54% +$93.4K ﹤0.01% 1052
2024
Q4 		$261K Sell
24,593
-4,980
-17% -$88.8K ﹤0.01% 980
2024
Q3 		$730K Sell
29,573
-4,613
-13% -$122K ﹤0.01% 750
2024
Q2 		$964K Sell
34,186
-3,980
-10% -$129K ﹤0.01% 667
2024
Q1 		$1.55M Buy
38,166
+10,583
+38% +$249K 0.01% 556
2023
Q4 		$455K Buy
27,583
+20,946
+316% +$365K ﹤0.01% 899
2023
Q3 		$252K Hold
6,637
– – ﹤0.01% 1009
2023
Q2 		$365K Buy
6,637
+220
+3% +$10.1K ﹤0.01% 951
2023
Q1 		$276K Sell
6,417
-116
-2% -$5.61K ﹤0.01% 1035
2022
Q4 		$257K Hold
6,533
– – ﹤0.01% 1084
2022
Q3 		$347K Hold
6,533
– – ﹤0.01% 1033
2022
Q2 		$429K Sell
6,533
-306
-4% -$20K ﹤0.01% 1019
2022
Q1 		$502K Buy
6,839
+4,712
+222% +$273K ﹤0.01% 1026
2021
Q4 		$151K Sell
2,127
-4
-0.2% -$698 ﹤0.01% 1359
2021
Q3 		$534K Sell
2,131
-1,113
-34% -$267K ﹤0.01% 1017
2021
Q2 		$873K Sell
3,244
-35
-1% -$10.5K ﹤0.01% 915
2021
Q1 		$933K Buy
+3,279
New +$1.05M ﹤0.01% 924

Other funds holding GBIO

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $790M AUM 223.66% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Los Angeles Capital Management's GBIO Position: Q2 2025 in Review

Los Angeles Capital Management sold out of Generation Bio (GBIO) in Q2 2025, closing a stake of 37,891 shares — an estimated $153K sold.

Los Angeles Capital Management first reported a position in GBIO in Q1 2021 and held it in 17 quarters. The position peaked at $1.55M in Q1 2024. 61 funds tracked by Wall St. Rank hold GBIO as of Q2 2025.

  • Los Angeles Capital Management reported no remaining Generation Bio position as of Q2 2025 after selling out during the quarter.
  • Los Angeles Capital Management sold 37,891 Generation Bio shares in Q2 2025, an estimated $153K.
  • Los Angeles Capital Management first reported a position in Generation Bio in Q1 2021 and held it in 17 quarters.
  • Los Angeles Capital Management's Generation Bio position peaked at $1.55M in Q1 2024.
  • 61 funds tracked by Wall St. Rank held Generation Bio as of Q2 2025.

Based on Los Angeles Capital Management's 13F filing for Q2 2025, filed 7 Aug 2025.